XML 47 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Issued capital
12 Months Ended
Jun. 30, 2022
Issued capital [Abstract]  
Issued capital
Note 21.  Issued capital

   
Consolidated
 
   
30 June 2022

   
30 June 2021

   
30 June 2022

   
30 June 2021
(restated*)
 
   
Shares
   
Shares
   
US$’000
   
US$’000
 
                         
Ordinary shares – fully paid and unrestricted
   
53,028,867
     
19,828,593
     
926,581
     
10,338
 

Movements in ordinary share capital
 
Details
 
Date
 
Shares
   
US$’000
 
                 
Balance
 
1 July 2020
   
19,828,593
     
10,338
 
                     
Balance
 
1 July 2021
   
19,828,593
     
10,338
 
Conversion of hybrid financial instruments
 
16 November 2021
   
24,835,118
     
695,383
 
Ordinary shares issued (IPO)
 
17 November 2021
   
8,269,231
     
231,539
 
Share-based payments, prepaid in advance
 
31 December 2021
   
95,925
     
177
 
IPO capital raise costs, net of tax
       
-
     
(10,856
)
                     
Balance
 
30 June 2022
   
53,028,867
     
926,581
 

Ordinary shares
Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the Company does not have a limited amount of authorized capital.

Initial Public offering
The Company listed its 55,036,108 ordinary shares on Nasdaq as part of an IPO on 17 November 2021. 8,269,231 ordinary shares were issued as part of this offering at a price of $28.00. Total proceeds (net of underwriting fees) of $215,330,775 were raised by the Group as part of this offering.

Conversion of hybrid financial instruments
On 16 November 2021, immediately prior to the IPO on 17 November 2021, all hybrid financial instruments (convertible notes and simple agreement for future equity ‘SAFE’) converted to equity in accordance with the underlying deeds. 24,835,118 ordinary shares were issued to noteholders on conversion of these instruments, resulting in a corresponding increase in issued capital of $695,383,000 (based on a conversion share price fair value of $28.00 on 16 November 2021). As at 30 June 2022, there are no outstanding convertible instruments issued by the Group.

Share based payments, prepaid in advance
During the year ended 30 June 2020, the Company issued 95,925 restricted share-based payments, prepaid in advance. The restrictions on these shares expired on 31 December 2021 with the corresponding liability converting to equity. As at 30 June 2022, there are no restricted share-based payments, prepaid in advance (30 June 2021: 95,925).

Loan-funded shares
As at 30 June 2022, there are 1,954,049 (30 June 2021: 2,260,614) restricted ordinary shares issued to management under the Employee Share Plan as well as certain non-employee founders of Podtech Innovation Inc. The total number of ordinary shares outstanding (including the restricted shares) is 54,982,916 as at 30 June 2022 (30 June 2021: 22,089,207).

Capital risk management
The Group’s objectives when managing capital is to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business.

Capital is regarded as total equity, as recognized in the consolidated statement of financial position, plus net debt. Net debt is calculated as total borrowings less cash and cash equivalents.

In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares, issue new debt or sell assets to reduce debt.